Skip to main content
NCBI home page
GeroScience logoLink to GeroScience
. 2019 Mar 22;41(5):631–641. doi: 10.1007/s11357-019-00059-1

Exploratory and locomotor activity, learning and memory functions in somatostatin receptor subtype 4 gene-deficient mice in relation to aging and sex

Nikolett Szentes 1, Valéria Tékus 1, Violetta Mohos 3, Éva Borbély 1, Zsuzsanna Helyes 1,2,✉
PMCID: PMC6885027  PMID: 30903571

Abstract

The inhibitory neuropeptide somatostatin regulates several functions in the nervous system including memory. Its concentrations decrease by age leading to functional alterations, but there are little known about the receptorial mechanism. We discovered that somatostatin receptor 4 (sst4) mediates analgesic, anti-depressant, and anti-inflammatory effects without endocrine actions, and it is a unique target for drug development. We investigated the exploratory and locomotor activities and learning and memory functions of male and female sst4gene-deficient mice compared with their wild-types (WT) at ages of 3, 12, 17 months in the Y-maze test, open field test (OFT), radial-arm maze (RAM) test and novel object recognition (NOR) test. Young sst4 gene-deficient females visited, repeated, and missed significantly less arms than the WTs in the RAM; males showed decreased exploration in the NOR. Young mice moved significantly more, spend longer time in OFT center, and visited more arms in the Y-maze than older ones. Young WT females spend significantly longer time in the OFT center, visited, missed and repeated more arms of the RAM than males. Old males found more rewards than females. Young males explored longer the novel object than young females and older males in the NOR; the recognition index was smaller in females. We conclude that aging and sex are important factors of behavioral parameters that should be focused on in such studies. Sst4 is likely to influence locomotion and exploratory behavior only in young mice, but not during normal aging, which is a beneficial feature of a good drug target focusing on the elderly.

Keywords: Somatostatin, sst4 receptor, Behavior, Exploratory, Memory, Locomotion

Introduction

Aging strongly influences cognitive functions, memory, and learning. Learning slows down, but memory does not necessarily worsen in the aging population that is continuously increasing in the twenty-first century. Identifying targets for cognitive impairment and memory deficits is in the focus of drug development (Martel et al. 2012). Besides aging, sex is also a crucial factor of cognitive performance (Ruan et al. 2017); therefore, it is important to analyze the differences in preclinical models. It is well established in a variety of species including humans (Vedovelli et al. 2017), rats (Casad 1990; Tenk et al. 2017), and mice (Ashpole et al. 2017; Fang et al. 2017; Reglodi et al. 2018; Spik and Sonntag 1989; Ungvari et al. 2017a) that peptide neurotransmitters, such as somatostatin, pituitary adenylate cyclase-activating polypeptide, corticotropin-releasing factor, insulin-like growth factor 1, growth hormone (GH), neurotrophic factor, connective tissue growth factor, play important regulatory roles in age-related diseases, and both their brain and peripheral concentrations change throughout aging.

Somatostatin is a 14 or 28 amino acid-containing peptide with a disulfide bridge discovered in the hypothalamus (Guillemin 1972) and originally described as a GH or somatotropin inhibiting factor (SRIF). Later it was characterized to be a broad spectrum inhibitory neurotransmitter with a complex effect throughout the central nervous system (CNS) (Epelbaum 1986; Martel et al. 2012; Viollet et al. 2008), as well as the periphery to mediate a variety of auto- , para- or endocrine actions (Leblanc et al. 1975; Pintér et al. 2006). Two subpopulations of somatostatinergic neurons can be distinguished in the CNS, long-protruding somatostatinergic neurons and short-proximal glutamate and gamma-aminobutyric acid (GABA)-ergic interneurons (Epelbaum 1986; Gulyás et al. 2003; Tomioka et al. 2005). Somatostatin inhibits the release of several excitatory and inhibitory neurotransmitters, such as serotonin, acetylcholine, glutamate, and GABA (Baraban and Tallent 2004). It plays a role in sensory perception and pain, motor functions, sleep, cognitive performance (Helyes et al. 2009; Matsuoka et al. 1994), and neurodegenerative disorders (Martel et al. 2012; Tuboly and Vecsei 2013), neuroendocrine and emotional regulation, anxiety and depression (Engin et al. 2008; Lin and Sibille 2015). Our team has provided strong proof-of-concept evidence for systemic anti-inflammatory and analgesic effects of somatostatin released from the activated capsaicin-sensitive peptidergic sensory nerves at the periphery called “sensocrine” function (Szolcsányi et al. 2004; Thán et al. 2000).

Brain somatostatin concentrations and its functions are strongly influenced by aging. Early gene expression studies demonstrated a significant reduction of somatostatin mRNA in the striatum, frontal, and parietal cortex, without significant changes in the hypothalamus of female Wistar rats (Florio et al. 1991). Furthermore, hypothalamic somatostatin immunoreactivity significantly decreases in aged female mice (Kuwahara et al. 2004) and rats (Kim and Choe 2018). In the frontal cortex, a certain somatostatinergic neuronal population is remarkably down-regulated (French et al. 2017). Somatostatin-induced GH-release inhibition was more sensitive in old animals (Kim and Choe 2018). Moreover, genetic deletion of somatostatin leads to reduced hippocampal neprilysin inactivity and increased Aβ42-formation also in young animals, which suggests a potential protective role of somatostatin in the development of Alzheimer’s disease and cognitive deficits (Saito et al. 2005). Despite all these data about the expressional and functional alterations of the somatostatinergic systems in the aging brain, very little is known about the regulation, sensitivity, and mechanisms of its receptors (Kim and Choe 2018).

The broad range of actions of somatostatin is mediated by its 5 Gi protein-coupled receptors (sst1–5) categorized into SRIF1 (sst2, 3, 5) and SRIF2 (sst1, 4) groups on the basis of synthetic agonist binding potentials (Hoyer et al. 1995). The SRIF2 receptors mediate the endocrine effect of somatostatin, while the SRIF1 ones are responsible for the anti-inflammatory, analgesic, anti-anxiety and anti-depressant actions (Prévôt et al. 2017; Scheich et al. 2016, 2017a). We discovered that the sst4 receptor is a very promising target to inhibit neurogenic inflammation, neuropathic pain, and depression (Scheich et al. 2016, 2017b), which was supported by others (Schuelert et al. 2015; Shenoy et al. 2018). Therefore, small molecule sst4 agonists are potential drug candidates as novel analgesic drugs with simultaneous anti-depressant activity (Botz et al. 2017; Scheich et al. 2016, 2017b). It is very important to elucidate the complex CNS functions of the sst4 receptor from this drug development point of view as well.

Although the precise expression of sst4 is not known due to the lack of reliable antibodies, data suggest that it is present in the hippocampus, striatum related to behavior, cognition, and memory (Gastambide et al. 2010; Nakagawasai et al. 2003; Schreff et al. 2000; Viollet et al. 1997), and a small molecule agonist was described to improve long-term and short-term learning in a mouse model of neurodegeneration (Gastambide et al. 2009; Sandoval et al. 2011).

Therefore, in the present study, we investigated the locomotor activity, anxiety, and memory functions in male and female mice throughout aging, as well as the role of the sst4 receptor on these parameters.

Materials and methods

Animals

We examined male and female sst4 gene-deficient mice (knockout, KO) (Helyes et al. 2009; Scheich et al. 2016, 2017b) and wild-type (WT) counterpart of three different ages (3, 12, 17-month-old) in different behavioral tests. They were bred and kept in the Laboratory Animal House of the Department of Pharmacology and Pharmacotherapy of the University of Pécs, Medical School. All animals were in standard plastic cages at 24–25 °C, under a 12–12 h light-dark cycle and provided by standard rodent chow and water ad libitum.

All experiments were carried out in accordance with the recommendations of the 1998/XXVIII Act of the Hungarian Parliament on Animal Protection (243/1988) and were approved by the Ethics Committee on Animal Research of Pécs University (license no. BA02/2000-76/2017).

Y-maze test

This test is suitable for rodent memory and route-learning capabilities, where we investigated the exploratory behavior of the mice for new ways (Holcomb et al. 1999; Hullmann et al. 2017). They were placed in the upper arm of the Y-shaped maze, each arm having the same length (35 cm), width (5 cm) and height (6 cm). Mice could freely move within the 5-min-period, the number of visited arms and the alternation index (%) (n(arm combination))/(n(total number of visited arms-2))×100 were determined.

Radial arm maze (RAM) test

This test is appropriate for investigating both short-term (working memory) and long-term (reference memory) memory functions (Frick et al. 1999; Gresack and Frick 2003).

It is constructed of eight arms with a well-defined central region where the mice start from. Each arm is 25 cm long, 7.5 cm wide, and 6 cm tall, the central part is 20 cm in diameter. Four sugar pellets (rewards) were placed in four defined arms, their locations did not change during the experiment. The entire study lasted for 4 days, the measurement time was 5 min every day in the arena. Mice were conditioned on the first 3 days, without and with rewards on the first and second/third days, respectively. The measurement used for evaluation was performed on the fourth day. The test lasted until the animal found all the four sugar pellets, but it was maximized for 5 min (Zhang and O’Donnell 2000). The number of visited, repeated (when the animal reentered a previously visited reward-containing arm), and missed arms (when the animal entered an arm that does not contain rewards), as well as the number of the found rewards and the time to find all the rewards were measured (Astur et al. 2004; Crusio and Schwegler 2005).

We determined the spatial working (the number of repeated arms divided by all visits, then multiplied by 100) and reference (the number of missed arms divided by all visits, then multiplied by 100) memory errors.

Novel object recognition (NOR) test

This test was carried out in a 40 × 40 cm high-walled box (open-field box) divided into 20 sections and lasted for 3 days. On the first day, the animals are habituated for 5 min, and the test served as an open field test (OFT) when the spontaneous locomotor activity and anxiety (time spent by moving, in the middle and at the periphery) were evaluated (Carola et al. 2002; Gaszner et al. 2012; Scheich et al. 2016). On the second day, two identical objects (smaller than the mouse) were placed in the test area, and the mice were allowed to familiarize with these objects for 5 min. On the third day (after 24 h), one object was replaced with a new one of different shape and color, and the animals have observed it for 5 min. We detected how much time the mice spend with the discovery of the familiar and the novel objects; the ratio of which was determined as the recognition index (Antunes and Biala 2012).

All experiments were recorded by the Noldus system and evaluated by the EthoVision XT software.

Statistical evaluation

Data are shown as means ± SEM, and factorial ANOVA followed by Tukey’s HSD post hoc test was used for statistical evaluation. Significant differences were highlighted in all figures as follows: *p < 0.05, **p < 0.01, ***p < 0.001 (related to age; older groups vs. young ones); #p < 0.05, ##p < 0.01, ###p < 0.001 (relates to sex; females vs. males); +p < 0.05, ++p < 0.01, +++p < 0.001 (related to genotype; KO vs. WT).

Results

Behavior of male and female sst4 KO mice of different ages in comparison with respective WT to controls in the Y-maze

Young male and female WT and sst4 gene-deficient mice visited significantly more arms than their older counterparts. Furthermore, the 17-month-old female WTs visited significantly less arms compared with males. Deletion of the sst4 receptor did not alter the behavior in this test in any age groups either in males or females. There were no significant differences in arm combinations in relation to age, sex, and sst4 receptor deletion (Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

a The total number of visited arms and b arm combination in the Y-maze test showing spatial working memory of mice by spontaneous alternation of male and female sst4 gene-deficient mice and WT counterparts of three different ages (3-, 12-, 17-months-old). c Representative heatmap pictures of male KO in the three different age groups. Data are means + SEM, *p < 0.05, **p < 0.01, ***p < 0.001 (vs. age); #p < 0.05 (vs. sex); factorial ANOVA followed by Tukey’s HSD post hoc test

Sst4 deficiency and aging worsen the RAM performance of female but not male mice

Young sst4 gene-deficient female mice visited, repeated, and missed significantly less arms than the WT counterparts. There was a remarkable sex difference in young mice, females repeated and missed significantly more arms than the males, and also visited more arms, although this parameter was not statistically significant. In the female, but not in the male WT group, young mice visited, repeated and missed more and found significantly more rewards than the respective old ones (Fig. 2).

Fig. 2.

Fig. 2

Open in a new tab

a The number of visited, b amount of reward found in the RAM. c Representative heatmap pictures of female WT in the three different age groups. Data are means + SEM, **p < 0.01, ***p < 0.001 (vs. age); #p < 0.05 (vs. sex); +p < 0.05 (vs. gene); factorial ANOVA followed by Tukey’s HSD post hoc test

Working and reference memory functions of male and female sst4 KO mice of different ages in comparison with respective WT controls in the RAM

Surprisingly, both aging and sst4 deletion significantly improved the working memory of female but not of male mice. However, the working memory of young and the reference memory of old WT female mice were worse than these functions of age-matched male controls, respectively (Fig. 3).

Fig. 3.

Fig. 3

Open in a new tab

a Working and b reference memory functions. Data are means + SEM, ***p < 0.001 (vs. age); #p < 0.05 (vs. sex); +p < 0.05 (vs. gene); factorial ANOVA followed by Tukey’s HSD post hoc test

Aging decreases spontaneous locomotor activity and increases anxiety level in both sexes independently of the sst4 receptor in the OFT

The 12- and 17-month-old mice of both sexes and genotypes moved significantly less during the 5-min measurement, spend less time in the middle and more at the periphery of the OF box than their young controls. It is also important to note that in the young WT group, females spend significantly more time in the middle and less at the periphery than the age-matched males (Fig. 4).

Fig. 4.

Fig. 4

Open in a new tab

a Time spend with moving, b distance moved, and c time spend in the middle in the open field box. Data are means + SEM, *p < 0.05, **p < 0.01, ***p < 0.001 (vs. age); #p < 0.05 (vs. sex); factorial ANOVA followed by Tukey’s HSD post hoc test

Decreased exploratory behavior in sst4-deficient young male, female and aged mice, but unaltered novelty detection and recognition memory functions in the NOR test

Young WT male mice spend significantly more time with both the familiar and novel objects then the sst4 gene-deficient ones, as well as the female counterparts and old ones both in cases of the first test (day 2) and the repeated test (day 3) (Fig. 5a–d).

graphic file with name 11357_2019_59_Fig5_HTML.jpg

Open in a new tab

The older, 12-, and 17-month-old mice of both sexes and genotypes were much less interested in exploring both objects. The recognition index determined by the ratio of the novel and the familiar object investigations showing the memory function did not show any difference in any groups (Fig. 5e).

Discussion

We show here that aging and sex are very important factors of behavioral parameters that have to be focused on in such studies. Furthermore, the somatostatin sst4 receptor is likely to be involved in locomotion and exploratory behaviors only in young mice and does not influence behavior during normal aging.

Somatostatin is expressed in brain regions related to pain and mood regulation like the dorsolateral prefrontal, cingulate cortex, and amygdala (Guilloux et al. 2012; Sibille et al. 2011; Tripp et al. 2011). Its important inhibitory functions in several physiological and pathophysiological processes, such as sensory, locomotion and motor coordination (Zeyda et al. 2001), stress-related and learning activities (Viollet et al. 2008), mood regulation (Engin et al. 2008; Lin and Sibille 2015), cognitive performance, and neurodegeneration (Saito et al. 2005) has also been evidenced in animal models. Furthermore, lower somatostatin levels were measured in the cerebrospinal fluid and the brain areas of patients with major and bipolar depressive disorders, schizophrenia, Alzheimer’s, and Parkinson’s diseases (Lin and Sibille 2013).

Somatostatin levels strongly decrease in the aging brain to that mRNA and protein levels (Florio et al. 1991; Kuwahara et al. 2004), and its functions are also altered (French et al. 2017; Kim and Choe 2018).

The expression of the sst4 receptor in the brain is similar to that of somatostatin (Martel et al. 2012), but there are no data about its functions and changes in aging. We earlier found enhanced inflammatory and neuropathic hyperalgesia in sst4-deleted mice (Helyes et al. 2009). Increased depression-like behaviors and anxiety, as well as altered neuronal activation in the central and basolateral amygdaloid nuclei, were detected in sst4 gene-deficient mice upon both acute and chronic stress (Scheich et al. 2017b).

The present results clearly demonstrate that the lack of sst4 only influences some behaviors of young mice: females visited, repeated, and missed significantly less arms than the WTs in the RAM, while males showed decreased exploration in the NOR. Since the outcomes of these behavioral tests are greatly modified by the anxiety level of the animals, and the sst4-deficient mice have more anxious and depressive-like phenotye (Scheich et al. 2016), our findings might not only be explained by the direct inhibition of learning and locomotion by somatostatin via this receptor, but higher stress level could also be an influencing factor.

Since substantial influence of aging and sex on the behavioral parameters in rodent experiments is well-established (Frick et al. 1999; Sutcliffe et al. 2007), we investigated the impact of these factors in our test systems in order to get a complex picture. The OFT (Carola et al. 2002) and the spontaneously alternating Y-maze test are suitable for determining spontaneous locomotor activity, exploratory behavior, and anxiety level (Borbély et al. 2013). Furthermore, the arm combination in the latter test also refers to working memory functions, since the animal has to remember the two arms that visited for the previous time to get the opportunity to choose and create a new alternative (Hughes 2004). Locomotor activity, anxiety, exploration time in both sexes, but working memory of females declined with age. Young males showed worse locomotor activity, higher anxiety, and better recognition memory, but old ones better working memory than females. Young mice moved significantly more, spend longer time in OFT center, and visited more arms in the Y-maze than older ones of both sexes. As for sex differences, we found that young females were more active than males, but the oldest females were less active and anxious than the respective males.

The influence of aging and sex on behavioral and memory parameters was investigated by others earlier with C57BL/6NIA mice. They found deteriorated memory with aging in both sexes up to 25 months in the Morris water maze, elevated plus maze, OFT that are in agreement with our findings. The 17-month-old mice showed less exploratory behavior, females had higher anxiety level and better spatial reference memory than males (Frick et al. 1999). Cognitive tests were performed in order to assess spontaneous movement, daily activity, distance moved, velocity, and acceleration in a 90-h period of time in young and old (C57B1/6J male 6, 21 and 27 months old) mice. Learning abilities and locomotor activity decreased age dependently and similarly to rats and humans. However, memory decline was not observed in all elderly mice (Logan et al. 2018). Furthermore, in a recent study, cognitive decline was investigated in C57BL/6J mice in the RAM test after brain irradiation which showed that this test is suitable method for assessing memory function in rodents (Ungvari et al. 2017b).

In both the RAM and NOR tests, the working and recognition memory of young animals were better, respectively. The NOR is widely used to examine memory processes (Bevins and Besheer 2006). Young WT females visited, missed, and repeated more arms of the RAM, but old males found more rewards. In the NOR, young males spend longer time by exploring the novel object than both young females and older males, the recognition index was smaller in females. Similarly to our mouse results here, male rats were shown to perform better in the recognition test (Sutcliffe et al. 2007).

There is a strong proof-of-concept that sst4 is a valuable target for the development of analgesic and anti-depressant, as well as anti-inflammatory drugs providing a unique tool for the treatment of these common comorbidities particularly in the elderly. Therefore, small molecule sst4 agonists with a completely new mechanism of action are under development for chronic neuropathic pain, concomitant mood disorders, and neurogenic inflammation that are still important unmet medical needs (Botz et al. 2017; Pintér et al. 2006; Scheich et al. 2016).

Synthetic sst4 agonists inhibit pain, inflammation (Sándor et al. 2006; Schuelert et al. 2015), depression-like behavior (Scheich et al. 2016), and as neurodegeneration and cognitive dysfunction via increasing neprilysin activity leading to decreased cortical Aβ1–42 formation in rodent models (Sandoval et al. 2011, 2012). We can conclude from the present results, that sst4 does not influence these functions during normal aging without more severe neuronal damage. Therefore, sst4 agonists, as novel drug candidates, are not likely to have a major influence on locomotion and learning ability.

Funding Information

Open access funding provided by University of Pécs (PTE). This research was supported by the National Brain Research Program (20017-1.2.1-NKP-2017-00002), 17886-4/2018/FEKUTSTRAT, GINOP-2.3.2-15-2016-00050 (“PEPSYS Complexity of peptidergic signalization and its role in systemic diseases”), EFOP-3.6.2-16-2017-00008 (“The role of neuro-inflammation in neurodegeneration: from molecules to clinics”), EFOP-3.6.1-16-2016-00004, EFOP-3.6.3-VEKOP-16-2017-00009.

Compliance with ethical standards

All experiments were carried out in accordance with the recommendations of the 1998/XXVIII Act of the Hungarian Parliament on Animal Protection (243/1988) and were approved by the Ethics Committee on Animal Research of Pécs University (license no. BA02/2000-76/2017).

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93–110. doi: 10.1007/s10339-011-0430-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashpole NM, Logan S, Yabluchanskiy A, Mitschelen MC, Yan H, Farley JA, Hodges EL, Ungvari Z, Csiszar A, Chen S, Georgescu C, Hubbard GB, Ikeno Y, Sonntag WE. IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan. Geroscience. 2017;39:129–145. doi: 10.1007/s11357-017-9971-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Astur R, Tropp J, Sava S, Constable RT, Markus EJ. Sex differences and correlations in a virtual Morris water task, a virtual radial arm maze, and mental rotation. Behav Brain Res. 2004;151:103–115. doi: 10.1016/j.bbr.2003.08.024. [DOI] [PubMed] [Google Scholar]
  4. Baraban SC, Tallent MK. Interneuron diversity series: Interneuronal neuropeptides - endogenous regulators of neuronal excitability. Trends Neurosci. 2004;27:135–142. doi: 10.1016/j.tins.2004.01.008. [DOI] [PubMed] [Google Scholar]
  5. Bevins RA, Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study “recognition memory”. Nat Protoc. 2006;1:1306–1311. doi: 10.1038/nprot.2006.205. [DOI] [PubMed] [Google Scholar]
  6. Borbély É, Scheich B, Helyes Z. Neuropeptides in learning and memory. Neuropeptides. 2013;47:439–450. doi: 10.1016/j.npep.2013.10.012. [DOI] [PubMed] [Google Scholar]
  7. Botz B, Bölcskei K, Helyes Z. Challenges to develop novel anti-inflammatory and analgesic drugs. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9:1–30. doi: 10.1002/wnan.1427. [DOI] [PubMed] [Google Scholar]
  8. Carola V, D’Olimpio F, Brunamonti E, Mangia F, Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mic. Behav Brain Res. 2002;134:49–57. doi: 10.1016/s0166-4328(01)00452-1. [DOI] [PubMed] [Google Scholar]
  9. Casad RC (1990) Studies with somatostatin and aging. Dissertation, Jr University of Michigan
  10. Crusio WE, Schwegler H. Learning spatial orientation tasks in the radial-maze and structural variation in the hippocampus in inbred mice. Behav Brain Funct. 2005;1:3. doi: 10.1186/1744-9081-1-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Engin E, Stellbrink J, Treit D, Dickson CT. Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence. Neuroscience. 2008;157:666–676. doi: 10.1016/j.neuroscience.2008.09.037. [DOI] [PubMed] [Google Scholar]
  12. Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol J Ep. 1986;271:63–100. doi: 10.1016/0301-0082(86)90012-2. [DOI] [PubMed] [Google Scholar]
  13. Fang Y, McFadden S, Darcy J, Hill CM, Huber JA, Verhulst S, Kopchick JJ, Miller RA, Sun LY, Bartke A. Differential effects of early-life nutrient restriction in long-lived GHR-KO and normal mice. Geroscience. 2017;39:347–356. doi: 10.1007/s11357-017-9978-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Florio T, Ventra C, Postiglione A, Schettini G. Age-related alterations of somatostatin gene expression in different rat brain areas. Brain Res. 1991;557:64–68. doi: 10.1016/0006-8993(91)90116-d. [DOI] [PubMed] [Google Scholar]
  15. French L, Ma TZ, Oh H, Tseng GC, Sibille E. Age-related gene expression in the frontal cortex suggests synaptic function changes in specific inhibitory neuron subtypes. Front Aging Neurosci. 2017;9:1–14. doi: 10.3389/fnagi.2017.00162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Frick KM, Burlingame LA, Arters JA, Berger-Sweeney J. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience. 1999;95:293–307. doi: 10.1016/s0306-4522(99)00418-2. [DOI] [PubMed] [Google Scholar]
  17. Gastambide F, Viollet C, Lepousez G, Epelbaum J, Guillou JL. Hippocampal SSTR4 somatostatin receptors control the selection of memory strategies. Psychopharmacology. 2009;202:153–163. doi: 10.1007/s00213-008-1204-x. [DOI] [PubMed] [Google Scholar]
  18. Gastambide F, Lepousez G, Viollet C, Loudes C, Epelbaum J, Guillou JL. Cooperation between hippocampal somatostatin receptor subtypes 4 and 2: functional relevance in interactive memory systems. Hippocampus. 2010;20:745–757. doi: 10.1002/hipo.20680. [DOI] [PubMed] [Google Scholar]
  19. Gaszner B, Kormos V, Kozicz T, Hashimoto H, Reglodi D, Helyes Z. The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger-Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus. Neuroscience. 2012;202:283–299. doi: 10.1016/j.neuroscience.2011.11.046. [DOI] [PubMed] [Google Scholar]
  20. Gresack JE, Frick KM. Male mice exhibit better spatial working and reference memory than females in a water-escape radial arm maze task. Brain Res. 2003;982:98–107. doi: 10.1016/s0006-8993(03)03000-2. [DOI] [PubMed] [Google Scholar]
  21. Guillemin R. Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control. Contraception. 1972;5:1–19. doi: 10.1016/0010-7824(72)90076-5. [DOI] [PubMed] [Google Scholar]
  22. Guilloux J, Douillard-Guilloux G, Kota R, Wang X, Martinowich K, Tseng GC, Lewis DA, Sibille E. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry. 2012;17:1130–1142. doi: 10.1038/mp.2011.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gulyás AI, Hájos N, Katona I, Freund TF. Interneurons are the local targets of hippocampal inhibitory cells which project to the medial septum. Eur J Neurosci. 2003;17:1861–1872. doi: 10.1046/j.1460-9568.2003.02630.x. [DOI] [PubMed] [Google Scholar]
  24. Helyes Z, Pintér E, Sándor K, Elekes K, Bánvölgyi Á, Keszthelyi D, Szőke É, Tóth DM, Sándor Z, Kereskai L, Pozsgai G, Allen JP, Emson PC, Markovics A, Szolcsányi J. Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice. Proc Natl Acad Sci. 2009;106:13088–13093. doi: 10.1073/pnas.0900681106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet. 1999;29:177–185. doi: 10.1023/A:1021691918517. [DOI] [PubMed] [Google Scholar]
  26. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Patel YC, Schonbrunn A, Taylor JE. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995;161:86–88. doi: 10.1016/s0165-6147(00)88988-9. [DOI] [PubMed] [Google Scholar]
  27. Hughes RN. The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory. Neurosci Biobehav Rev. 2004;28:497–505. doi: 10.1016/j.neubiorev.2004.06.006. [DOI] [PubMed] [Google Scholar]
  28. Hullmann M, Albrecht C, van Berlo D, Gerlofs-Nijland ME, Wahle T, Boots AW, Krutmann J, Cassee FR, Bayer TA, Schins RPF. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer’s disease. Part Fibre Toxicol. 2017;14:1–14. doi: 10.1186/s12989-017-0213-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kim K, Choe HK. Role of hypothalamus in aging and its underlying cellular mechanisms. Mech Ageing Dev. 2018;177:74–79. doi: 10.1016/j.mad.2018.04.008. [DOI] [PubMed] [Google Scholar]
  30. Kuwahara S, Kesuma Sari D, Tsukamoto Y, Tanaka S, Sasaki F. Age-related changes in growth hormone (GH)-releasing hormone and somatostatin neurons in the hypothalamus and in GH cells in the anterior pituitary of female mice. Brain Res. 2004;1025:113–122. doi: 10.1016/j.brainres.2004.08.012. [DOI] [PubMed] [Google Scholar]
  31. Leblanc H, Anderson JR, Sigel MB, Yen SSC. Inhibitory action of somatostatin on pancreatic α and β cell function. J Clin Endocrinol Metab. 1975;40:568–572. doi: 10.1210/jcem-40-4-568. [DOI] [PubMed] [Google Scholar]
  32. Lin LC, Sibille E. Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target? Front Pharmacol. 2013;4:1–12. doi: 10.3389/fphar.2013.00110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lin LC, Sibille E. Somatostatin, neuronal vulnerability and behavioral emotionality. Mol Psychiatry. 2015;20:377–387. doi: 10.1038/mp.2014.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Logan S, Owen D, Chen S, Chen WJ, Ungvari Z, Farley J, Csiszar A, Sharpe A, Loos M, Koopmans B, Richardson A, Sonntag WE. Simultaneous assessment of cognitive function, circadian rhythm, and spontaneous activity in aging mice. Geroscience. 2018;40:123–137. doi: 10.1007/s11357-018-0019-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Martel G, Dutar P, Epelbaum J, Viollet C. Somatostatinergic systems: an update on brain functions in normal and pathological aging. Front Endocrinol (Lausanne) 2012;3:154. doi: 10.3389/fendo.2012.00154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matsuoka N, Maeda N, Yamaguchi I, Satoh M. Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Res. 1994;642:11–19. doi: 10.1016/0006-8993(94)90900-8. [DOI] [PubMed] [Google Scholar]
  37. Nakagawasai O, Hozumi S, Tan-No K, Niijima F, Arai Y, Yasuhara H, Tadano T. Immunohistochemical fluorescence intensity reduction of brain somatostatin in the impairment of learning and memory-related behaviour induced by olfactory bulbectomy. Behav Brain Res. 2003;142:63–67. doi: 10.1016/s0166-4328(02)00383-2. [DOI] [PubMed] [Google Scholar]
  38. Pintér E, Helyes Z, Szolcsányi J. Inhibitory effect of somatostatin on inflammation and nociception. Pharmacol Ther. 2006;112:440–456. doi: 10.1016/j.pharmthera.2006.04.010. [DOI] [PubMed] [Google Scholar]
  39. Prévôt TD, Gastambide F, Viollet C, Henkous N, Martel G, Epelbaum J, Béracochéa D, Guillou JL. Roles of hippocampal somatostatin receptor subtypes in stress response and emotionality. Neuropsychopharmacology. 2017;42:1647–1656. doi: 10.1038/npp.2016.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Reglodi D, Atlasz T, Szabo E, Jungling A, Tamas A, Juhasz T, Fulop BD, Bardosi A. PACAP deficiency as a model of aging. Geroscience. 2018;40:437–452. doi: 10.1007/s11357-018-0045-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ruan Q, D’Onofrio G, Sancarlo D, Greco A, Lozupone M, Seripa D, Panza F, Yu Z. Emerging biomarkers and screening for cognitive frailty. Aging Clin Exp Res. 2017;29:1075–1086. doi: 10.1007/s40520-017-0741-8. [DOI] [PubMed] [Google Scholar]
  42. Saito T, Iwata N, Tsubuki S, Takaki Y, Takano J, Huang SM, Suemoto T, Higuchi M, Saido TC. Somatostatin regulates brain amyloid β peptide Aβ42 through modulation of proteolytic degradation. Nat Med. 2005;11:434–439. doi: 10.1038/nm1206. [DOI] [PubMed] [Google Scholar]
  43. Sándor K, Elekes K, Szabó Á, Pintér E, Engström M, Wurster S, Szolcsányi J, Helyes Z. Analgesic effects of the somatostatin sst4 receptor selective agonist J-2156 in acute and chronic pain models. Eur J Pharmacol. 2006;539:71–75. doi: 10.1016/j.ejphar.2006.03.082. [DOI] [PubMed] [Google Scholar]
  44. Sandoval KE, Farr SA, Banks WA, Niehoff ML, Morley JE, Crider AM, Witt KA. Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. Eur J Pharmacol. 2011;654:53–59. doi: 10.1016/j.ejphar.2010.12.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Sandoval KE, Farr SA, Banks WA, Crider AM, Morley JE, Witt KA. Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ1-42 trimers. Eur J Pharmacol. 2012;683(1–3):116–124. doi: 10.1016/j.ejphar.2012.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Scheich B, Gaszner B, Kormos V, László K, Ádori C, Borbély É, Hajna Z, Tékus V, Bölcskei K, Ábrahám I, Pintér E, Szolcsányi J, Helyes Z. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models. Neuropharmacology. 2016;101:204–215. doi: 10.1016/j.neuropharm.2015.09.021. [DOI] [PubMed] [Google Scholar]
  47. Scheich B, Cseko K, Borbely E, Abraham I, Csernus V, Gaszner B, Helyes Z. Higher susceptibility of somatostatin 4 receptor gene-deleted mice to chronic stress-induced behavioral and neuroendocrine alterations. Neuroscience. 2017;346:320–336. doi: 10.1016/j.neuroscience.2017.01.039. [DOI] [PubMed] [Google Scholar]
  48. Scheich B, Vincze P, Szőke É, Borbély É, Hunyady Á, Szolcsányi J, Dénes Á, Környei Z, Gaszner B, Helyes Z. Chronic stress-induced mechanical hyperalgesia is controlled by capsaicin-sensitive neurones in the mouse. Eur J Pain (United Kingdom) 2017;21:1417–1431. doi: 10.1002/ejp.1043. [DOI] [PubMed] [Google Scholar]
  49. Schreff M, Schulz S, Händel M, Keilhoff G, Braun H, Pereira G, Klutzny M, Schmidt H, Wolf G, Höllt V. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain. J Neurosci. 2000;20:3785–3797. doi: 10.1523/JNEUROSCI.20-10-03785.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schuelert N, Just S, Kuelzer R, Corradini L, Gorham LCJ, Doods H. The somatostatin receptor 4 agonist J-2156 reduces mechanosensitivity of peripheral nerve afferents and spinal neurons in an inflammatory pain model. Eur J Pharmacol. 2015;746:274–281. doi: 10.1016/j.ejphar.2014.11.003. [DOI] [PubMed] [Google Scholar]
  51. Shenoy PA, Kuo A, Khan N, Gorham L, Nicholson JR, Corradini L, Vetter I, Smith MT. The somatostatin receptor-4 agonist J-2156 alleviates mechanical hypersensitivity in a rat model of breast cancer induced bone pain. Front Pharmacol. 2018;9:495. doi: 10.3389/fphar.2018.00495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Sibille E, Morris HM, Kota RS, Lewis DA. GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol. 2011;14:721–734. doi: 10.1017/S1461145710001616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Spik K, Sonntag WE. Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology. 1989;50:489–494. doi: 10.1159/000125269. [DOI] [PubMed] [Google Scholar]
  54. Sutcliffe JS, Marshall KM, Neill JC. Influence of gender on working and spatial memory in the novel object recognition task in the rat. Behav Brain Res. 2007;177:117–125. doi: 10.1016/j.bbr.2006.10.029. [DOI] [PubMed] [Google Scholar]
  55. Szolcsányi J, Pintér E, Helyes Z. Sensocrine function of capsaicin-sensitive nociceptors mediated by somatostatin regulates against inflammation and hyperalgesia. Hyperalgesia: molecular mechanisms and clinical implication. In: Handwerker HO, Brune K, editors. Process in pain research and Mamagement. Seattle: IASP Press; 2004. pp. 113–128. [Google Scholar]
  56. Tenk J, Rostás I, Füredi N, Mikó A, Solymár M, Soós S, Gaszner B, Feller D, Székely M, Pétervári E, Balaskó M. Age-related changes in central effects of corticotropin-releasing factor (CRF) suggest a role for this mediator in aging anorexia and cachexia. Geroscience. 2017;39:61–72. doi: 10.1007/s11357-017-9962-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Thán M, Németh J, Szilvássy Z, Pintér E, Helyes Z, Szolcsányi J. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and Guinea-pig. Eur J Pharmacol. 2000;399:251–258. doi: 10.1016/s0014-2999(00)00341-1. [DOI] [PubMed] [Google Scholar]
  58. Tomioka R, Okamoto K, Furuta T, Fujiyama F, Iwasato T, Yanagawa Y, Obata K, Kaneko T, Tamamaki N. Demonstration of long-range GABAergic connections distributed throughout the mouse neocortex. Eur J Neurosci. 2005;21:1587–1600. doi: 10.1111/j.1460-9568.2005.03989.x. [DOI] [PubMed] [Google Scholar]
  59. Tripp A, Kota RS, Lewis DA, Sibille E. Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol Dis. 2011;42:116–124. doi: 10.1016/j.nbd.2011.01.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Tuboly G, Vecsei L. Somatostatin and cognitive function in neurodegenerative disorders. Mini-Rev Med Chem. 2013;13:34–46. doi: 10.2174/138955713804484794. [DOI] [PubMed] [Google Scholar]
  61. Ungvari Z, Valcarcel-Ares MN, Tarantini S, Yabluchanskiy A, Fülöp GA, Kiss T, Csiszar A. Connective tissue growth factor (CTGF) in age-related vascular pathologies. Geroscience. 2017;39:491–498. doi: 10.1007/s11357-017-9995-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Ungvari Z, Tarantini S, Hertelendy P, Valcarcel-Ares MN, Fülöp GA, Logan S, Kiss T, Farkas E, Csiszar A, Yabluchanskiy A. Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence. Geroscience. 2017;39:33–42. doi: 10.1007/s11357-017-9964-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Vedovelli K, Giacobbo BL, Corrêa MS, Wieck A, de Argimon IIL, Bromberg E. Multimodal physical activity increases brain-derived neurotrophic factor levels and improves cognition in institutionalized older women. Geroscience. 2017;39:407–417. doi: 10.1007/s11357-017-9987-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Viollet C, Bodenant C, Prunotto C, Roosterman D, Schaefer J, Meyerhof W, Epelbaum J, Vaudry H, Leroux P. Differential expression of multiple somatostatin receptors in the rat cerebellum during development. J Neurochem. 1997;68:2263–2272. doi: 10.1046/j.1471-4159.1997.68062263.x. [DOI] [PubMed] [Google Scholar]
  65. Viollet C, Lepousez G, Loudes C, Videau C, Simon A, Epelbaum J. Somatostatinergic systems in brain: networks and functions. Mol Cell Endocrinol. 2008;286:75–87. doi: 10.1016/j.mce.2007.09.007. [DOI] [PubMed] [Google Scholar]
  66. Zeyda T, Diehl N, Paylor R, Brennan MB, Hochgeschwender U. Impairment in motor learning of somatostatin null mutant mice. Brain Res. 2001;906:107–114. doi: 10.1016/s0006-8993(01)02563-x. [DOI] [PubMed] [Google Scholar]
  67. Zhang HT, O’Donnell JM. Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology. 2000;150:311–316. doi: 10.1007/s002130000414. [DOI] [PubMed] [Google Scholar]

Articles from GeroScience are provided here courtesy of Springer

RESOURCES